Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - RTI SURGICAL, INC. | Financial_Report.xls |
| 10-Q - FORM 10-Q - RTI SURGICAL, INC. | d226024d10q.htm |
| EX-31.1 - CERTIFICATION - RTI SURGICAL, INC. | d226024dex311.htm |
| EX-31.2 - CERTIFICATION - RTI SURGICAL, INC. | d226024dex312.htm |
| EX-32.1 - CERTIFICATION - RTI SURGICAL, INC. | d226024dex321.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of RTI Biologics, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert P. Jordheim, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Robert P. Jordheim |
Dated: November 4, 2011 | |||
| Robert P. Jordheim |
||||
| Executive Vice President and Chief Financial Officer |
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of this Report or as a separate disclosure document. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.